Clinical benefits of Livin peptide-loaded DCs/CIKs combined with chemotherapy in advanced non-small cell lung cancer.

Zhang, Luping; Xu, Zihan; Chen, Xiewan; Duan, Yuzhong; Chen, Zhengtang; Sun, Jianguo

Zhang, Luping; Xu, Zihan; Chen, Xiewan; Duan, Yuzhong; Chen, Zhengtang; Sun, Jianguo.

Afiliación

Zhang L; Cancer Institute of People's Liberation Army, Xinqiao Hospital, Army Medical University Chongqing, People's Republic of China.
Xu Z; Cancer Institute of People's Liberation Army, Xinqiao Hospital, Army Medical University Chongqing, People's Republic of China.
Chen X; Department of Medical English, College of Basic Medicine, Army Medical University Chongqing, People's Republic of China.
Duan Y; Cancer Institute of People's Liberation Army, Xinqiao Hospital, Army Medical University Chongqing, People's Republic of China.
Chen Z; Cancer Institute of People's Liberation Army, Xinqiao Hospital, Army Medical University Chongqing, People's Republic of China.
Sun J; Cancer Institute of People's Liberation Army, Xinqiao Hospital, Army Medical University Chongqing, People's Republic of China.

Am J Cancer Res ; 9(2): 406-414, 2019.

Article en En | MEDLINE | ID: mdl-30906637

Palabras clave

Dendritic cells; Livin peptide; cytokine-induced killer cells; cytotherapy; non-small-cell lung cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google